Topics

FDA approves AstraZeneca diabetes drug for treating heart failure risk

04:08 EDT 21 Oct 2019 | Reuters

AstraZeneca's diabetes drug Farxiga has been approved for use in the United States as a treatment to reduce the chances of hospitalisation for heart failure in adults with type-2 diabetes and other cardiovascular risks, the British drugmaker said on ...

Original Article: FDA approves AstraZeneca diabetes drug for treating heart failure risk

NEXT ARTICLE

More From BioPortfolio on "FDA approves AstraZeneca diabetes drug for treating heart failure risk"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...